SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 📊Experiments 🤖Agents 🚦Status 📑Docs

Info

ℹVision ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

Vision Showcase Demo

Home / Wiki / Therapy: MSA Combination Therapy

therapy 3,049 words KG: MSA 2026-03-23

kind:therapy-idea section:ideas state:published

Contents

MSA Combination Therapy

Knowledge Graph

Related Hypotheses (28)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.41 Smartphone-Detected Motor Variability Correction
Score: 0.65 Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.50 Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.49 Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.80

Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.77 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.77 CYP46A1 Overexpression Gene Therapy
Score: 0.75 Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.65 PARP1 Inhibition Therapy
Score: 0.64 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.62 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.61 Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.60 Vocal Cord Neuroplasticity Stimulation
Score: 0.58 Ganglioside Rebalancing Therapy
Score: 0.57 Vagal Afferent Microbial Signal Modulation
Score: 0.57 Orexin-Microglia Modulation Therapy
Score: 0.56 Lysosomal Calcium Channel Modulation Therapy
Score: 0.56 Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.56 Complement C1q Mimetic Decoy Therapy
Score: 0.55 TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.55 Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.54 Hypocretin-Neurogenesis Coupling Therapy
Score: 0.53 HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.52 Arginine Methylation Enhancement Therapy
Score: 0.51 R-Loop Resolution Enhancement Therapy
Score: 0.51 SIRT6-NAD+ Axis Enhancement Therapy
Score: 0.48 Glial Glycocalyx Remodeling Therapy
Score: 0.48

Related Analyses (18)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived

What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived

Related Experiments (8)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Iron Dyshomeostasis in MSA Pathogenesis Experiment
validation · proposed · Score: 0.40 Longitudinal TLR2 reporter gene study in α-synuclein mice
validation · proposed · Score: 0.90 Dexamethasone treatment study in α-synuclein mice
validation · proposed · Score: 0.85 TLR expression in α-synuclein overexpressing mice
validation · proposed · Score: 0.80

Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40 tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.40 Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.40

See Also (4)

Synucleinopathies
mechanism · KG edge: contributes_to Packard Center for ALS Research
institution · KG edge: associated_with Neurodegeneration
disease · KG edge: associated_with Parkinson Basal Ganglia Circuit
circuit · KG edge: co_discussed

Knowledge Graph (12 edges)

MSA contributes_to synucleinopathies

MSA co_discussed PARKINSON

MSA co_discussed PARKINSON'S

MSA associated_with NEURODEGENERATION

MSA associated_with SCHIZOPHRENIA

MSA co_discussed SNCA

MSA co_discussed MULTIPLE SCLEROSIS

MSA co_discussed NEURODEGENERATION

MSA co_discussed STING

MSA co_discussed MTOR

SciDEX — scidex.ai — Dashboard | Atlas